This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by WOOD, J. C. Articles by CONN, H. L. Search for Related Content PubMed PubMed Citation Articles by WOOD, J. C. Articles by CONN, H. L., JR.

(Circulation. 1954;10:517.)
© 1954 American Heart Association, Inc.

---

Prevention of Systemic Arterial Embolism in Chronic Rheumatic Heart Disease by Means of Protracted Anticoagulant Therapy

JOHN C. WOOD M.D.¹ HADLEY L. CONN JR. M.D.¹

¹ From the Edward B. Robinette Foundation, Medical Clinic, Hospital of the University of Pennsylvania, Philadelphia, Pa.

Seven clinic outpatients with mitral stenosis and auricular fibrillation complicated by systemic embolism have been maintained on Dicumarol for periods of 20 to 48 months. None has had a recognized embolism while on therapy. Dicumarol administration has been interrupted in each case for periods of six days to four months. Three additional systemic embolic episodes in two individuals occurred during this interval. Hemorrhagic manifestations have occurred on three occasions. The study suggests that: (a) protracted Dicumarol therapy is an effective means of preventing recurrent embolism in individuals with chronic rheumatic heart disease; (b) it is applicable to the average clinic outpatient.

This article has been cited by other articles:

				M. J. WAHL MYTHS OF DENTAL SURGERY IN PATIENTS: RECEIVING ANTICOAGULANT THERAPY J Am Dent Assoc, January 1, 2000; 131(1): 77 - 81. [Abstract] [Full Text] [PDF]

				M. J. Wahl Dental Surgery in Anticoagulated Patients Arch Intern Med, August 10, 1998; 158(15): 1610 - 1616. [Abstract] [Full Text]